Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-12

Clinical Trial Update: Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease

View source ↗

Summary

A completed clinical trial evaluated whether measuring fractional exhaled nitric oxide (FeNO) could identify eosinophilic airway inflammation in adults aged 40 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Aerocrine AB | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Status: COMPLETED | Results posted: 2014-02-12